“Pharma Bro” Martin Shkreli’s former company and former business partner agreed to settle legal claims arising from the company’s purchase of and 4,000% price increase on the drug Daraprim.
“Pharma Bro’s” ex-Company and ex-Partner Settling Claims Arising from Daraprim “Scheme,” FTC Says
“Pharma Bro” Martin Shkreli’s former company and former business partner agreed Tuesday to settle legal claims brought against them by the U.S. and seven state governments arising from the company’s purchase of and 4,000% price increase on the drug Daraprim, which is used to treat toxoplasmosis in patients with HIV.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.